“If anyone else had done this to me, I would have gone to the police. But it was an utterly useless thought to have, if only because I knew that I would never, ever, have let anyone else do that to me ...

In case you've faced some hurdles solving the clue, Me too!, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world. Today, Austin Carr reports on the frenemy AI competition in which Microsoft is ...

Eight years ago today, the “Me Too” hashtag became a global rallying cry for survivors of sexual violence. Now, the movement is stepping into a new era with its inaugural Disruptor Council, bringing ...

The council consists of gamechangers such as Viola Davis, Gabrielle Union, and Rep. Ayanna Pressley. “me too.” International, the anti-sexual violence organization co-founded by Tarana Burke, has ...

Tarana Burke is done waiting for the conversation about sexual violence to change on its own. So, she’s decided to change it herself. Today, the ‘me too.’ International co-founder unveiled the new ...

Two years ago, I started hearing sounds from my body — whispers in the form of aches, fatigue and odd little symptoms that didn’t quite add up. I was a thriving mother, a shareholder in a multimillion ...

Ayo Edebiri is being praised on social media for how she handled an uncomfortable interview moment while promoting her new movie, “After the Hunt,” at the Venice Film Festival. “The Bear” Emmy winner ...

Despite being awkwardly excluded from a question about the state of the industry, Ayo Edebiri has earned praise for her answer. When asked by Italian journalist Federica Polidoro what was “lost during ...

It has certainly been a day for Matt Riddle. The former WWE star and current MLW World Heavyweight Champion was accused this morning of no-showing a charity wrestling event in the UK over this past ...

In an analysis of all FDA approvals for anticancer drugs from 2009 to 2020, only about 29% of next-in-class drugs were evaluated in head-to-head randomized clinical trials (RCTs) against their ...